Our findings showed verbascoside has anti-tumor activity against breast cancer cells by initiating apoptosis cascade followed by activating MyD88 pathway and reducing NF-κB at mRNA level with no toxic effect on normal cells. Here, NFKB1 is linked to breast cancer.